225 related articles for article (PubMed ID: 34710950)
41. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
42. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.
Clemente LP; Rabenau M; Tang S; Stanka J; Cors E; Stroh J; Culmsee C; von Karstedt S
Cells; 2020 Oct; 9(10):. PubMed ID: 33050207
[TBL] [Abstract][Full Text] [Related]
43. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
44. Biodegradable and Efficient Charge-Migrated Z-Scheme Heterojunction Amplifies Cancer Ferroptosis by Blocking Defensive Redox System.
Liu Y; Yi Y; Sun S; Wang T; Tang J; Peng Z; Huang W; Zeng W; Wu M
Small; 2024 Jun; 20(23):e2309206. PubMed ID: 38149505
[TBL] [Abstract][Full Text] [Related]
45. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.
Zhou TJ; Zhang MM; Liu DM; Huang LL; Yu HQ; Wang Y; Xing L; Jiang HL
Biomaterials; 2024 Mar; 305():122447. PubMed ID: 38154441
[TBL] [Abstract][Full Text] [Related]
46. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells.
Sun Y; Zheng Y; Wang C; Liu Y
Cell Death Dis; 2018 Jul; 9(7):753. PubMed ID: 29988039
[TBL] [Abstract][Full Text] [Related]
47. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
[TBL] [Abstract][Full Text] [Related]
48. l-Arginine-Modified CoWO
Yang Z; Yang C; Yang D; Zhang Y; Yang Q; Qu F; Guo W
Adv Healthc Mater; 2023 Jul; 12(18):e2203092. PubMed ID: 36907173
[TBL] [Abstract][Full Text] [Related]
49. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
[TBL] [Abstract][Full Text] [Related]
50. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
[TBL] [Abstract][Full Text] [Related]
51. Inhalable Biomimetic Protein Corona-Mediated Nanoreactor for Self-Amplified Lung Adenocarcinoma Ferroptosis Therapy.
Wang W; Fu F; Huang Z; Wang W; Chen M; Yue X; Fu J; Feng X; Huang Y; Wu C; Pan X
ACS Nano; 2022 May; 16(5):8370-8387. PubMed ID: 35575209
[TBL] [Abstract][Full Text] [Related]
52. Multi-enzyme Co-expressed Dual-Atom Nanozymes Induce Cascade Immunogenic Ferroptosis via Activating Interferon-γ and Targeting Arachidonic Acid Metabolism.
Liu Y; Niu R; Deng R; Song S; Wang Y; Zhang H
J Am Chem Soc; 2023 Apr; 145(16):8965-8978. PubMed ID: 37058189
[TBL] [Abstract][Full Text] [Related]
53. Inhalable Biomineralized Liposomes for Cyclic Ca
Fu F; Wang W; Wu L; Wang W; Huang Z; Huang Y; Wu C; Pan X
ACS Nano; 2023 Mar; 17(6):5486-5502. PubMed ID: 36883602
[TBL] [Abstract][Full Text] [Related]
54. Identification and initial characterization of a potent inhibitor of ferroptosis.
Kuganesan N; Dlamini S; McDaniel J; Tillekeratne VLM; Taylor WR
J Cell Biochem; 2021 Apr; 122(3-4):413-424. PubMed ID: 33377232
[TBL] [Abstract][Full Text] [Related]
55. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy.
Niu B; Liao K; Zhou Y; Wen T; Quan G; Pan X; Wu C
Biomaterials; 2021 Oct; 277():121110. PubMed ID: 34482088
[TBL] [Abstract][Full Text] [Related]
56. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.
Yang WS; Kim KJ; Gaschler MM; Patel M; Shchepinov MS; Stockwell BR
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E4966-75. PubMed ID: 27506793
[TBL] [Abstract][Full Text] [Related]
57. Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.
Liu Z; Kang R; Yang N; Pan X; Yang J; Yu H; Deng W; Jia Z; Zhang J; Shen Q
J Colloid Interface Sci; 2024 Mar; 658():100-113. PubMed ID: 38100967
[TBL] [Abstract][Full Text] [Related]
58. Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer.
Huang QF; Li YH; Huang ZJ; Jun M; Wang W; Chen XL; Wang GH
Eur J Pharm Biopharm; 2023 Sep; 190():284-293. PubMed ID: 37532638
[TBL] [Abstract][Full Text] [Related]
59. Nitric oxide protects against ferroptosis by aborting the lipid peroxidation chain reaction.
Homma T; Kobayashi S; Conrad M; Konno H; Yokoyama C; Fujii J
Nitric Oxide; 2021 Oct; 115():34-43. PubMed ID: 34329739
[TBL] [Abstract][Full Text] [Related]
60. PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization.
Wang H; Zhang L; Miao Z; Zhang M; Liu H; He Q; Meng J; Wen L; Ke Z; Zha Z; Lin R; Liang C
Mater Horiz; 2021 Aug; 8(8):2216-2229. PubMed ID: 34846426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
